Clinical Profile, Comorbidities and Therapies in Type 2 Diabetes Patients on Sitagliptin-Based Therapy in Indian Outpatient Setting.
印度門診環境中接受Sitagliptin治療的2型糖尿病患者的臨床特徵、共病及療法。
Cureus 2024-12-31
Effect of sodium glucose cotransporter-2 inhibitors (SGLT-2is) on the clinical outcomes of patients with diabetic atrial fibrillation.
鈉葡萄糖共轉運蛋白-2 抑制劑 (SGLT-2is) 對糖尿病性心房顫動患者臨床結果的影響。
BMC Cardiovasc Disord 2024-12-30
Dapagliflozin in acute heart failure management: a systematic review and meta-analysis of safety and effectiveness.
急性心衰竭管理中的 Dapagliflozin:安全性和有效性的系統評價與荟萃分析。
BMC Cardiovasc Disord 2024-12-28
Discontinuation rates, clinical effects and provocation factors of SGLT-2 inhibitor in the real world.
SGLT-2 抑制劑在真實世界中的停藥率、臨床效果及誘發因素。
Sci Rep 2024-12-27
Drug Interaction of SGLT2Is and ARNI on Acute Kidney Injury: A Real-world Pharmacovigilance Analysis Through the FAERS.
SGLT2抑制劑與ARNI對急性腎損傷的藥物相互作用:通過FAERS的實際世界藥物監測分析。
J Cardiovasc Pharmacol 2024-12-27
The efficacy and safety of Empagliflozin on outcomes of patients with myocardial infarction undergoing primary PCI: a systematic review and meta-analysis.
Empagliflozin 對接受初次經皮冠狀介入治療 (PCI) 的心肌梗塞患者結果的療效與安全性:系統性回顧與統合分析。
Naunyn Schmiedebergs Arch Pharmacol 2024-12-27